0001127602-25-017498.txt : 20250613 0001127602-25-017498.hdr.sgml : 20250613 20250613162600 ACCESSION NUMBER: 0001127602-25-017498 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250516 FILED AS OF DATE: 20250613 DATE AS OF CHANGE: 20250613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Basil Michelle L CENTRAL INDEX KEY: 0001699629 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 251046969 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0329 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4/A 1 form4a.xml PRIMARY DOCUMENT X0508 4/A 2025-05-16 2025-05-20 0000313143 HAEMONETICS CORP HAE 0001699629 Basil Michelle L 125 SUMMER STREET BOSTON MA 02110 1 EVP and General Counsel 0 Common Stock 2025-05-16 4 A 0 6755 A 35233 D Non-qualified Stock Option (Right to Buy) 70.31 2025-05-16 4 A 0 14626 0 A 2032-05-16 Common Stock 14626 14626 D The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of RSUs awarded to be 5,689 instead of 6,755. This net increase of 1,066 RSUs, and the corresponding change in securities beneficially owned by the reporting person, will be reflected in future filings by the reporting person. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. This number includes unvested RSUs previously reported. On May 20, 2025, the reporting person filed a Form 4 that incorrectly showed the amount of options awarded to be 12,317 instead of 14,626. This net increase of 2,309 options will be reflected in future filings by the reporting person. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Ms. Basil 2025-06-13